Pharmaceutical Industry Today

Protein Phosphatase 2A Market 2018 : Ampio Pharmaceuticals Inc, Cyano Biotech GmbH, Lixte Biotechnology Holdings Inc, and PEP-Therapy SAS with their unique quality of simplifying the market research study, presents a deep diving study report “Protein Phosphatase 2A (PP2A or EC - Pipeline Review, H2 2017”
Published 07 February 2018


Protein Phosphatase 2A (PP2A or EC - Protein Phosphatase 2A (PP2A) is an enzyme encoded by the PPP2CA gene. PP2A plays important roles in regulation of cell cycle, signal transduction, cell differentiation, and transformation. Its activity is related to several diseases, including neurodegenerative diseases and cancer.

The report 'Protein Phosphatase 2A - Pipeline Review, H2 2017' outlays comprehensive information on the Protein Phosphatase 2A (PP2A or EC targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

Click here for sample report @

Top Companies mentioned

Ampio Pharmaceuticals Inc

Cyano Biotech GmbH

Lixte Biotechnology Holdings Inc

PEP-Therapy SAS

Re-Pharm Ltd

Signum Biosciences Inc

Protein Phosphatase 2A Industry Major Highlights:

  • The report provides a snapshot of the global therapeutic landscape for Protein Phosphatase 2A (PP2A or EC
  • The report reviews Protein Phosphatase 2A (PP2A or EC targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Protein Phosphatase 2A (PP2A or EC targeted therapeutics and enlists all their major and minor projects
  • The report assesses Protein Phosphatase 2A (PP2A or EC targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news and deals related to Protein Phosphatase 2A (PP2A or EC targeted therapeutics

Reasons to buy

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand the targeted therapy areas and indications for Protein Phosphatase 2A (PP2A or EC
  • Identify the use of drugs for target identification and drug repurposing
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Protein Phosphatase 2A (PP2A or EC development landscape
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Competitive Analysis for Protein Phosphatase 2A

Key players are making innovative developments in Protein Phosphatase 2A industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector.


For Detailed Reading Please visit @

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Other Industry News

Ready to start publishing

Sign Up today!